Page Menu

UMMS researchers receive funding from Gilbert Family Foundation to develop NF1 therapeutic

Date Posted: Thursday, December 13, 2018

The Gilbert Family Foundation has announced that UMass Medical School will receive funding from a $12 million gene therapy initiative to address the underlying cause of neurofibromatosis type 1. UMMS investigators will work to accelerate the development of therapies that address the core genetic abnormalities in NF1 patients. The funding is part of the Gilbert Family Foundation’s Gene Therapy Initiative, a three-year initiative to identify promising gene therapy techniques for NF1.

For more information please read...

Additional Resources
click to open search panel